Adoption of Digital Health Technologies in the Practice of Behavioral Health

This is the title of a paper published today with co-authors Suepattra May, Caroline Huber, Meaghan Roach, Wade Aubry, Darius Lakdawalla, John Kane, and Felicia Forma. The subtitle is “Qualitative Case Study of Glucose Monitoring Technology“. The abstract is below. Background: Evaluation of patients with serious mental illness (SMI) relies largely on patient or caregiver…

How good is your mental health care? Depends where you live

Access to physician services and pharmaceuticals is vital–particularly among patients with serious mental illness–to insure patients receive the care they need. However, the likelihood patients receive this care depends on where they live. A paper by Manchester (2018) examines a cohort of patients eligible for both Medicare and U.S. Social Security Disability Insurance (SSDI) and…

Economics of mental health

Pharmafile has an interesting article on the “Economics of Mental Health”.  The article has a number of interesting statistics: The cost: “Mental health issues have been estimated to cost the world economy $2.5 trillion each year. To put that into perspective, the United Kingdom’s gross domestic product (GDP) was $2.6 trillion in 2017.” Costs extend…

Does physician knowledge of patient non-compliance change prescribing behavior in the real world?

This is the topic of a recent publication with co-authors Kata Bognar, Katie Everson, Michelle Brauer, Darius Lakdawalla and Felicia Forma.  The full title is Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness.  The abstract is below, but do read the whole thing…